Cargando…

In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect

Human coronaviruses SARS-CoV-2 appeared at the end of 2019 and led to a pandemic with high morbidity and mortality. As there are currently no effective drugs targeting this virus, drug repurposing represents a short-term strategy to treat millions of infected patients at low costs. Hydroxychloroquin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreani, Julien, Le Bideau, Marion, Duflot, Isabelle, Jardot, Priscilla, Rolland, Clara, Boxberger, Manon, Wurtz, Nathalie, Rolain, Jean-Marc, Colson, Philippe, La Scola, Bernard, Raoult, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182748/ https://www.ncbi.nlm.nih.gov/pubmed/32344177 http://dx.doi.org/10.1016/j.micpath.2020.104228

Ejemplares similares

Methylene blue inhibits replication of SARS-CoV-2 in vitro
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
por: Gendrot, Mathieu, et al.
Publicado: (2020)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020)

In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2021)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

High-speed large-scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled to high-content screening
por: Francis, Rania, et al.
Publicado: (2021)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Testing of Aircraft Wastewater Shows That Mandatory Tests and Vaccination Pass before Boarding Did Not Prevent Massive Importation of Omicron Variant into Europe
por: Le Targa, Lorlane, et al.
Publicado: (2022)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells
por: de Souza, Gabriel Augusto Pires, et al.
Publicado: (2021)

Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
por: Delandre, Océane, et al.
Publicado: (2022)

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
por: La Scola, Bernard, et al.
Publicado: (2020)

Case Report: Clostridium neonatale Bacteremia in a Preterm Neonate With Necrotizing Enterocolitis
por: Cassir, Nadim, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile
por: Wurtz, Nathalie, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
por: Hache, Guillaume, et al.
Publicado: (2021)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2020)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Innovative Approach to Fast Electron Microscopy Using the Example of a Culture of Virus-Infected Cells: An Application to SARS-CoV-2
por: Le Bideau, Marion, et al.
Publicado: (2021)

Limited permissibility of ENL-R and Mv-1-Lu mink cell lines to SARS-CoV-2
por: Le Bideau, Marion, et al.
Publicado: (2022)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Experimental Inoculation in Rats and Mice by the Giant Marseillevirus Leads to Long-Term Detection of Virus
por: Aherfi, Sarah, et al.
Publicado: (2018)

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
por: Million, Matthieu, et al.
Publicado: (2020)

Choosing a cellular model to study SARS-CoV-2
por: Pires De Souza, Gabriel Augusto, et al.
Publicado: (2022)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2022)

Isolation and Characterization of Kingella bonacorsii sp. nov., A Novel Kingella Species Detected in a Stable Periodontitis Subject
por: Antezack, Angéline, et al.
Publicado: (2021)

Monitoring the Circulation of SARS-CoV-2 Variants by Genomic Analysis of Wastewater in Marseille, South-East France
por: Wurtz, Nathalie, et al.
Publicado: (2021)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
por: Brouqui, Philippe, et al.
Publicado: (2023)

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
por: Gautret, Philippe, et al.
Publicado: (2020)

Core gene-based molecular detection and identification of Acanthamoeba species
por: Chelkha, Nisrine, et al.
Publicado: (2020)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Synergistic Adverse Effects of Azithromycin and Hydroxychloroquine on Human Cardiomyocytes at a Clinically Relevant Treatment Duration
por: Li, Wener, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hvjkd7eu7k2vi4ner7eor28ak5